April 26, 2019
Rose
There's been more and more scrutiny over how pharma companies use patents to find loopholes in anti-competition laws. Now Sen. John Cornyn (R-Texas) is going after a practice where companies make minor formula adjustments to prevent generic substitutions. In other pharmaceutical news: more kickback settlements, pharma-funded charities, first-quarter profits, copays and more.
from Kaiser Health News http://bit.ly/2vmYTR1
April 26, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Price-Fixing Investigation: Patients Say They Couldn’t Afford Crucial Psychiatric Drug After Generic Companies Hiked Cost- With Health Law Vote, Senate Dems Hope To Put Republicans On Record Against Preexisting Conditions Coverage
- New Hampshire Study Shines Light On Strong Link Between Childhood Traumas, Substance Misuse Later In Life
- ‘A Lot Of Promise’: DeepMind Algorithm Detects Serious Kidney Condition In Minutes, But Miss Rate Is High
- Georgia’s Hopes For Generous Federal Funding To Expand Medicaid Dim Following Utah Rejection
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment